These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 35795500)

  • 21. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.
    Cinesi Gómez C; Peñuelas Rodríguez Ó; Luján Torné M; Egea Santaolalla C; Masa Jiménez JF; García Fernández J; Carratalá Perales JM; Heili-Frades SB; Ferrer Monreal M; de Andrés Nilsson JM; Lista Arias E; Sánchez Rocamora JL; Garrote JI; Zamorano Serrano MJ; González Martínez M; Farrero Muñoz E; Mediano San Andrés O; Rialp Cervera G; Mas Serra A; Hernández Martínez G; de Haro López C; Roca Gas O; Ferrer Roca R; Romero Berrocal A; Ferrando Ortola C
    Med Intensiva (Engl Ed); 2020 Oct; 44(7):429-438. PubMed ID: 32312600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol.
    Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D
    Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Imperfect Cytokine Storm: Severe COVID-19 With ARDS in a Patient on Durable LVAD Support.
    Chau VQ; Oliveros E; Mahmood K; Singhvi A; Lala A; Moss N; Gidwani U; Mancini DM; Pinney SP; Parikh A
    JACC Case Rep; 2020 Jul; 2(9):1315-1320. PubMed ID: 32292915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19.
    Azkur AK; Akdis M; Azkur D; Sokolowska M; van de Veen W; Brüggen MC; O'Mahony L; Gao Y; Nadeau K; Akdis CA
    Allergy; 2020 Jul; 75(7):1564-1581. PubMed ID: 32396996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal septic shock due to Capnocytophaga canimorsus bacteremia masquerading as COVID-19 pneumonia - a case report.
    Meyer EC; Alt-Epping S; Moerer O; Büttner B
    BMC Infect Dis; 2021 Aug; 21(1):736. PubMed ID: 34344315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
    Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising gas therapies for severe COVID-19.
    Wang T; Xiang Q; Bian J
    J Intensive Med; 2021 Oct; 1(2):99-102. PubMed ID: 36943807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
    Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
    BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report.
    Sahin Tutak A; Söylemez F; Konuk HB; Çakmak E; Karakaya B; Doğan A; Sayiner HS; Aksöz S; Alev M
    J Infect Public Health; 2021 Oct; 14(10):1395-1397. PubMed ID: 34175235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
    Nagarkatti P; Miranda K; Nagarkatti M
    Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
    Torabi-Rahvar M; Rezaei N
    Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological diagnosis of Coronavirus-related nephropathy: insight from postmortem studies.
    Sanguedolce F; Zanelli M; Froio E; Bisagni A; Zizzo M; Ascani S; Stallone G; Netti S; Ranieri E; Falagario U; Carrieri G; Cormio L
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):563-575. PubMed ID: 34236278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
    Mannino F; Bitto A; Irrera N
    Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shelter from the cytokine storm: Healthy living is a vital preventative strategy in the COVID-19 era.
    Arena R; Bond S; Calvo IR; Lebowicz L; Ozemek C; Severin R; Laddu D; Faghy MA; Lavie CJ; Carbone S;
    Prog Cardiovasc Dis; 2022; 73():56-60. PubMed ID: 34153291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is Poliomyelitis Sequelae A Disadvantage for Recovery from Covid-19 ARDS: A Case Report.
    Topaloğlu M; Turan Z; Tekin S; Şentürk E; Özyemişçi Taşkiran Ö
    Noro Psikiyatr Ars; 2022; 59(2):158-160. PubMed ID: 35685049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.